Novarex Coltd Stock Fundamentals
| 194700 Stock | KRW 7,380 90.00 1.23% |
NOVAREX CoLtd fundamentals help investors to digest information that contributes to NOVAREX CoLtd's financial success or failures. It also enables traders to predict the movement of NOVAREX Stock. The fundamental analysis module provides a way to measure NOVAREX CoLtd's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NOVAREX CoLtd stock.
NOVAREX |
NOVAREX CoLtd Company Current Valuation Analysis
NOVAREX CoLtd's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current NOVAREX CoLtd Current Valuation | 406.97 B |
Most of NOVAREX CoLtd's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NOVAREX CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, NOVAREX CoLtd has a Current Valuation of 406.97 B. This is much higher than that of the sector and significantly higher than that of the Personal Products industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.
NOVAREX CoLtd Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NOVAREX CoLtd's current stock value. Our valuation model uses many indicators to compare NOVAREX CoLtd value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NOVAREX CoLtd competition to find correlations between indicators driving NOVAREX CoLtd's intrinsic value. More Info.NOVAREX CoLtd is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers reporting about 0.01 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for NOVAREX CoLtd is roughly 176.17 . Comparative valuation analysis is a catch-all model that can be used if you cannot value NOVAREX CoLtd by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for NOVAREX CoLtd's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.NOVAREX Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NOVAREX CoLtd's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NOVAREX CoLtd could also be used in its relative valuation, which is a method of valuing NOVAREX CoLtd by comparing valuation metrics of similar companies.NOVAREX CoLtd is rated third in current valuation category among its peers.
NOVAREX Fundamentals
| Return On Equity | 16.33 | |||
| Return On Asset | 0.0927 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 406.97 B | |||
| Shares Outstanding | 7.95 M | |||
| Shares Owned By Insiders | 38.56 % | |||
| Shares Owned By Institutions | 4.31 % | |||
| Price To Sales | 1.13 X | |||
| Revenue | 278.79 B | |||
| Gross Profit | 39.11 B | |||
| EBITDA | 33.46 B | |||
| Net Income | 30.65 B | |||
| Cash And Equivalents | 19.17 B | |||
| Total Debt | 22.58 B | |||
| Debt To Equity | 0.45 % | |||
| Current Ratio | 1.45 X | |||
| Cash Flow From Operations | 24.13 B | |||
| Target Price | 23000.0 | |||
| Number Of Employees | 323 | |||
| Beta | 0.7 | |||
| Market Capitalization | 83.88 B | |||
| Total Asset | 254.63 B | |||
| Z Score | 2.8 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 254.63 B |
About NOVAREX CoLtd Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NOVAREX CoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NOVAREX CoLtd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NOVAREX CoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.NOVAREX Co., Ltd. develops and produces health functional foods and raw materials in South Korea and internationally. NOVAREX Co., Ltd. was founded in 2008 and is headquartered in Cheongju, South Korea. NOVAREX is traded on Korean Securities Dealers Automated Quotations in South Korea.
Pair Trading with NOVAREX CoLtd
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NOVAREX CoLtd position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NOVAREX CoLtd will appreciate offsetting losses from the drop in the long position's value.Moving together with NOVAREX Stock
The ability to find closely correlated positions to NOVAREX CoLtd could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NOVAREX CoLtd when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NOVAREX CoLtd - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NOVAREX CoLtd to buy it.
The correlation of NOVAREX CoLtd is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NOVAREX CoLtd moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NOVAREX CoLtd moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NOVAREX CoLtd can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in NOVAREX Stock
NOVAREX CoLtd financial ratios help investors to determine whether NOVAREX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NOVAREX with respect to the benefits of owning NOVAREX CoLtd security.